Immix Biopharma (IMMX) Net earnings per share growth forecast for next year

Symbol and logo of brand Immix Biopharma, Inc. (IMMX)

Immix Biopharma, Inc. (IMMX) attracts talented scientists with a flexible startup culture, yet the lack of guaranteed success for early-stage developments and the need for secondary offerings create significant risks. This earnings per share (EPS) forecast chart helps assess the trend, where the -31.80 metric confirms the current level. The company's competitive advantage is based on patents in tissue-specific therapy and CAR-T engineering.

IMMX - Immix Earnings growth forecast for next year over the range 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for Immix Biopharma, Inc. (IMMX)

- price and consensus price forecast:
Analysis of all company metrics:Immix Biopharma, Inc.
Core merchandise of Immix

The indicator synthesizes current analyst estimates for earnings per share (EPS) dynamics, transforming complex discounting models into a daily trend of expected returns. This metric measures the fundamental growth potential of the business, where a positive trajectory signals market optimism regarding future cash flows. The success of Immix Biopharma, Inc. (IMMX) partnerships in the field of immunotherapy for rare cancers directly determines this forward-looking EPS growth benchmark.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|ALX Oncology Holdings - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Cue Biopharma|Earnings growth forecast for next year pdsbiotech.com|Net earnings per share growth forecast for next year sonnetbio.com (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year